Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Chelsea Therapeutics International Ltd CHTP

Healthcare Biotechnology

Recent & Breaking News (NDAQ:CHTP)

Lundbeck Completes Acquisition of Chelsea Therapeutics

Business Wire June 24, 2014

NORTHERA(TM) Clinical Trial Data Published in Neurology

GlobeNewswire June 19, 2014

Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Movement Disorders

GlobeNewswire June 12, 2014

Chelsea Therapeutics Announces the Expiration of the Hart-Scott-Rodino Waiting Period in Relation to the Proposed Acquisition of Chelsea Therapeutics by Lundbeck

GlobeNewswire June 6, 2014

The Law Office of Robbins Arroyo LLP Announces Class Action Lawsuit Against Chelsea Therapeutics International, Ltd.

PR Newswire June 2, 2014

Chelsea Therapeutics Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate the Acquisition Proposal from H. Lundbeck A/S

Business Wire May 21, 2014

Acquisition Chelsea Therapeutics International, Ltd by H. Lundbeck A/S May Not Be in Shareholders' Best Interests

PR Newswire May 12, 2014

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Chelsea Therapeutics International, Ltd.

Business Wire May 9, 2014

Harwood Feffer LLP Announces Investigation of Chelsea Therapeutics International, Ltd.

PR Newswire May 9, 2014

Lifshitz & Miller Law Firm Announces Investigation of Chelsea Therapeutics International Ltd., KBR, Inc., OmniAmerican Bancorp, Inc., PokerTek, Inc., SP Bancorp, Inc. and 1st United Bancorp, Inc.

PR Newswire May 9, 2014

Ryan & Maniskas, LLP Announces Investigation of Chelsea Therapeutics International Ltd.

PR Newswire May 9, 2014

Newman Ferrara LLP Announces Investigation of Chelsea Therapeutics International Ltd.

Business Wire May 9, 2014

SHAREHOLDER ALERT: Brower Piven Announces the Investigation of Chelsea Therapeutics International, Ltd. in Connection with the Proposed Sale of the Company to H. Lundbeck A/S

Business Wire May 8, 2014

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders

Business Wire May 8, 2014

SHAREHOLDER ALERT: The Law Office of James C. Kelly Investigates Claims That the Proposed Acquisition of Chelsea Therapeutics International, Ltd. May Not Be in its Investors' Best Interests

PR Newswire May 8, 2014

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Directors In Connection With the Sale of the Company to H. Lundbeck A/S -- CHTP

PR Newswire May 8, 2014

CHELSEA THERAPEUTICS INTERNATIONAL, LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

Business Wire May 8, 2014

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Directors In Connection With the Sale of the Company to H. Lundbeck A/S

Business Wire May 8, 2014

Chelsea Therapeutics Investor Buyout Alert - Acquisition Of Chelsea Therapeutics - Leading National Securities Law Firm Seeks Higher Price For Shareholders

PR Newswire May 8, 2014

Chelsea Therapeutics to Host Conference Call to Discuss Acquisition by Lundbeck

GlobeNewswire May 8, 2014